The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
2 marketed package NDCs · 1 active manufacturer
Most dispensed: RISANKIZUMAB 150 mg/mL · Injection · #1 syringe/carton / 1 ml in 1 syringe · Kit · #1 kit/carton * 2.4 ml in 1 cartridge * 2.4 ml in 1 cartridge
Only one company currently supplies this market — there is no backup if it stumbles.
Every detected change for risankizumab-rzaa, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Interleukin-23 Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.